MA04.02 Responses and Durability in NSCLC Treated With Pegilodecakin and Anti-PD-1
Garon, E., Wong, D., Schneider, J., Aljumaily, R., Korn, W., Infante, J., Patel, M., Autio, K., Papadopoulos, K., Naing, A., Gabrail, N., Munster, P., Goldman, J., Hung, A., Van Vlasselaer, P., LevequVolume:
13
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2018.08.341
Date:
October, 2018
File:
PDF, 207 KB
english, 2018